Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 15, 2025, Glaukos (GKOS) has a market cap of $5.35 billion USD. According to our data, Glaukos is ranked No.2459 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 15, 2025 | $5.35 B |
-35.33%
|
| Dec 31, 2024 | $8.27 B |
88.63%
|
| Dec 29, 2023 | $4.38 B |
81.98%
|
| Dec 30, 2022 | $2.41 B |
-1.71%
|
| Dec 31, 2021 | $2.45 B |
-40.95%
|
| Dec 31, 2020 | $4.15 B |
38.17%
|
| Dec 31, 2019 | $3.00 B |
-3.03%
|
| Dec 31, 2018 | $3.10 B |
118.99%
|
| Dec 29, 2017 | $1.41 B |
-25.22%
|
| Dec 30, 2016 | $1.89 B |
38.92%
|
| Dec 31, 2015 | $1.36 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Alcon
ALC
|
$45.22 B |
-0.002 M
|
Switzerland
|
 Bausch + Lomb
BLCO
|
$4.21 B |
0.000 M
|
Canada
|
 STAAR Surgical
STAA
|
$0.81 B |
-0.000 M
|
USA
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Santen Pharmaceutical
4536.T
|
$3.27 B |
68.032 M
|
Japan
|
 Hoya
7741.T
|
$36.73 B |
-0.851 B
|
Japan
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Abbott Laboratories
ABT
|
$218.91 B |
-0.002 M
|
USA
|
 Medtronic
MDT
|
$105.64 B |
0.002 M
|
Ireland
|
 Cooper Companies
COO
|
$15.56 B |
-0.001 M
|
USA
|
 Ocular Therapeutix
OCUL
|
$1.20 B |
-0.000 M
|
USA
|
| Market Cap | = | GKOS Stock Price | * | GKOS Shares Outstanding |
| = | $94.52 | * | 56.57 M | |
| = | $5.35 B |